Skip to navigationSkip to content
  • A-Z Medicines
  • FAQ
  • Subscribe
Logo: Department of Health, Disability and AgeingLogo: Pharmaceutical Benefits Scheme
medicine search
  • Home
  • PBS Information
    • About the PBS
    • PBS Contacts
    • Latest News
    • Subscribe to PBS News
    • Frequently asked questions
    • Pharmaceutical Benefits Advisory Committee (PBAC)
    • Medicine Status
    • Eighth Community Pharmacy Agreement (8CPA)
    • PBS Process Improvements
    • Biosimilars on the PBS
    • PBS Publications
    • PBS Downloads
    • PBS Reviews
    • PBS Statistics
    • Committees
    • Working Groups
    • Report adverse drug reactions
    • PBS Mobile website
    • PBS Software Developers
  • Browse the PBS
    • New,amended and deleted
    • 60-day prescriptions
    • A-Z medicine listing
    • Biological Medicines
    • Body system
    • Botulinum Toxin Program
    • Continued Dispensing Arrangements
    • Dental Items
    • Efficient Funding of Chemotherapy
    • Growth Hormone Program
    • Highly Specialised Drugs Program
    • IVF Program
    • Manufacturer / Supplier
    • Midwife Items
    • Nurse Practitioner Items
    • Opioid Dependence Treatment Program
    • Optometrical Items
    • Palliative Care Items
    • Prescriber Bag Supplies
    • Repatriation (RPBS)
    • Safety Net early supply
    • Section 100
    • Streamlined Authorities
    • Supply Only
    • Therapeutic group
    • Explanatory notes
      • Fees & Patient Contributions
      • Standard Packs and Prices
      • Extemporaneously-Prepared
    • Price Premiums
      • Brand Premium
      • Therapeutic group premium
      • Special patient contribution
  • For Health Professionals
    • For PBS Prescribers
    • For Pharmacists
  • For Industry
    • How to List on the PBS
    • Pricing Matters
    • Supply Matters
    • PBS Statistics
    • Useful Resources
    • Industry FAQ
    • PBAC Meetings
    • PBAC Guidelines
    • PBS Calendars
    • PBS Forms
    • Health Products Portal
  • News
    • Latest News
    • Subscribe to News Updates
  • Publications & Downloads
    • PBS Publications
    • Downloads
  • Contacts

Refine search

To refine your search select one of the options below.

Body System Antineoplastic And Immunomodulating Agents (4259),Genito Urinary System And Sex Hormones (12),Systemic Hormonal Preparations, Excl. Sex Hormones And Insulins (2)
Schedule Chemotherapy Items for Private Hospital use (316),Chemotherapy Items for Private Hospital use (48),Chemotherapy Items for Public Hospital use (316),Chemotherapy Items for Public Hospital use (48),General Schedule (2461),Repatriation Pharmaceutical Benefits (5),S100 HSD Private (521),S100 HSD Public (521),S100 IVF (1),Section 100 (CT) (22)
Prescriber Medical Practitioners (4259),Nurse Practitioners (148)

ABATACEPT

  • abatacept 125 mg/mL injection, 4 x 1 mL pen devices
  • abatacept 125 mg/mL injection, 4 x 1 mL syringes
  • abatacept 250 mg injection, 1 vial

ABEMACICLIB

  • abemaciclib 50 mg tablet, 56
  • abemaciclib 100 mg tablet, 56
  • abemaciclib 150 mg tablet, 56

ABIRATERONE

  • abiraterone acetate 500 mg tablet, 60
  • abiraterone acetate 250 mg tablet, 120

ABIRATERONE (&) METHYLPREDNISOLONE

  • abiraterone acetate 125 mg tablet [120] (&) methylprednisolone 4 mg tablet [60], 1 pack
  • abiraterone acetate 125 mg tablet [120] (&) methylprednisolone 4 mg tablet [30], 1 pack

ACALABRUTINIB

  • acalabrutinib 100 mg tablet, 56

ADALIMUMAB

  • adalimumab 20 mg/0.2 mL injection, 2 x 0.2 mL syringes
  • adalimumab 80 mg/0.8 mL injection, 0.8 mL pen device
  • adalimumab 80 mg/0.8 mL injection, 0.8 mL syringe
  • adalimumab 20 mg/0.4 mL injection, 2 x 0.4 mL syringes
  • adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices
  • adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL syringes
  • adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes
  • adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL pen devices
  • adalimumab 20 mg/0.4 mL injection, 0.4 mL syringe

AFATINIB

  • afatinib 20 mg tablet, 28
  • afatinib 30 mg tablet, 28
  • afatinib 40 mg tablet, 28
  • afatinib 50 mg tablet, 28

ALECTINIB

  • alectinib 150 mg capsule, 4 x 56

ALEMTUZUMAB

  • alemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial

AMIVANTAMAB

  • amivantamab 350 mg/7 mL injection, 7 mL vial
loading
More Medicine

Department of Health, Disability and Ageing

Logo: Department of Health, Disability and Ageing

Pharmaceutical Benefits Scheme

PBS Logo

© Commonwealth of Australia
ABN: 83 605 426 759

PBS Information

  • About the PBS
  • Frequently asked questions
  • Pharmaceutical Benefits Advisory Committee (PBAC)
  • Publications & Downloads
  • PBS Reviews
  • PBS Statistics
  • Report adverse drug reactions
  • PBS Mobile website
  • PBS Software Developers
  • Latest News
  • Subscribe to PBS News
  • PBS Contacts

Browse the PBS

  • New, amended and deleted
  • A-Z medicine listing
  • Repatriation (RPBS)
  • Explanatory notes
  • Body system
  • Dental Items
  • Prescriber Bag Supplies
  • Midwife Items
  • Nurse Practitioner Items
  • Optometrical Items
  • Palliative Care Items
  • Section 100
  • Manufacturer / Supplier
  • Safety Net Scheme
  • Streamlined Authorities
  • Therapeutic Group
  • Browse Price Premiums

For Health Professionals

  • For PBS Prescribers
  • For Pharmacists
  •  
  •  
  • ABOUT
  • About This Site
  • Contact Us
  • Accessibility
  • Privacy
  • Disclaimer
  • Copyright

For Industry

  • How to List on the PBS
  • The Listing Steps
  • Elements of the listing process
  • Participants in the listing process
  • Pricing Matters
  • Pricing of PBS Items
  • Price Disclosure (SPD)
  • PBS Statistics
  • Useful Resources
  • Pharmaceutical Benefits Advisory Committee (PBAC)